Progesterone receptor status of breast cancer metastases

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 1, 2002, Pages 55-60

  Brankovic Magic M ^a   Jankovic R ^a   Neskovic Konstantinovic Z ^a   Nikolic Vukosavljevic D ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Breast cancer; Metastatic progesterone receptors; Therapeutic response

Indexed keywords

PROGESTERONE RECEPTOR; STEROID RECEPTOR; TAMOXIFEN;

ARTICLE; BREAST METASTASIS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; PHENOTYPE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HUMANS; LYMPHATIC METASTASIS; METHOTREXATE; MIDDLE AGED; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TAMOXIFEN; TIME FACTORS;

EID: 0036181508     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-001-0299-9     Document Type: Article

References (29)

1. Variations in the content of steroid receptors in breast cancer. Comparison between primary tumors and metastatic lesions
2. Steroid receptors in pleural effusions of advanced breast cancer patients
3. Assessment of response to treatment in advanced breast cancer
4. Progesterone receptors as a prognostic factor in stage II breast cancer
5. The process of malignant progression in human breast cancer
6. Receptor status variation in primary breast cancer and subsequent accessible relapse
7. Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients
8. Receptor heterogeneity of human breast cancer as measured by multiple intratumoral assays of estrogen and progesterone receptor
9. Revision of the standards for the assessment of hormone receptors in human breast cancer
10. Recurrence-free survival in breast cancer improved by adjuvant tamoxifen - Especially for progesterone receptor positive tumors with high proliferation
11. Steroid hormone receptors and hormonal therapies in human breast cancer
12. Steroid hormone receptors and antineoplastic chemotherapy in human breast cancer
13. Does the oestrogen receptor concentration of the breast cancer patients change during systemic therapy?
14. Treatment of metastatic breast: Present and future prospects
15. Assessment of response to therapy in advanced breast cancer
16. Does receptor status in breast cancer vary with time, site and treatment?
17. The prognostic significance of steroid receptor activity in tumor tissues of patients with primary breast cancer
18. The comparative diagnostic accuracy of cancer-cell detection obtained with ficoll-hypaque gradient separation and standard centrifugation techniques on body-cavity fluids
19. Loss of estrogen receptor in recurrent breast cancer is associated with poor response to endocrine therapy
20. Protein measurement with the folin phenol reagent
21. CEA and CA 15-3 in pleural effusion of advanced breast cancer patients: Clinical relevance and diagnostic value
22. Standardization of steroid receptor assay
23. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: Results of prospective Southwest Oncology Group Study
24. Steroid receptor distribution in 47892 breast cancers. A collaborative study of 7 European laboratories
25. Attraction of proteins for small molecules and ions
26. Sequential estrogen receptor determinations from primary breast cancer and at relapse: Prognostic and therapeutic relevance
27. Steroid and peptide hormone receptors identified in breast tissue